15 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 24
Maravai Lifesciences Reports First Quarter 2024 Financial Results
4:09pm
current or future products.
The risk that a future cyber-attack or security breach cannot be prevented.
Maravai’s ability to protect
DRS/A
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Draft registration statement (amended)
12:00am
, laboratory and office closures and an increased reliance on employees working from home, travel limitations, cyber security and data accessibility … of our customers, collaborators or other contractors, have been and may in the future be subject to cyber-attacks or security breaches, which could
DRS
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 Sep 20
Draft registration statement
12:00am
reliance on employees working from home, travel limitations, cyber security and data accessibility limits, or communication or mass transit disruptions … .
Our internal computer systems, or those of our customers, collaborators or other contractors, have been and may in the future be subject to cyber
10-K
2020 FY
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Mar 21
Annual report
4:22pm
limitations, cyber security and data accessibility limits, or communication or mass transit disruptions; and
limitations on employee resources that would … , collaborators or other contractors, have been and may in the future be subject to cyber-attacks or security breaches, which could result in a material
DRS/A
ran09ru6y5y7ez0
23 Oct 20
Draft registration statement (amended)
12:00am
424B4
rvnjkyp
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
iexv1a14xv8w4om ldi7
29 Oct 20
IPO registration
5:04pm
8-K
EX-1.1
9qw5ls1iwnljqja2qa
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-2.1
7p5x7uwkhqs09e0ib1t
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
- Prev
- 1
- Next